We are investigating the safety of a new treatment called NRG5051 in healthy adults and patients with Parkinson's disease or ALS. This research aims to understand how the drug affects different groups of people.
Health conditions and diseases that the clinical trial is designed to study and treat.
Parkinson's Disease is a progressive neurological disorder that affects movement, causing tremors, stiffness, and balance issues. Amyotrophic Lateral Sclerosis (ALS) is a serious condition that affects nerve cells in the brain and spinal cord, leading to muscle weakness and atrophy. Together, these conditions can significantly impact mobility and daily activities.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.